Abstract
Adolescent alcohol use is one of the strongest predictors for the development of an alcohol use disorder (AUD). Notably, this period of risk coincides with the development of affective disorders, which disproportionately impact and drive problematic drinking behavior in women. Stress is a particularly salient factor that drives relapse during periods of abstinence. Previous work in our lab has shown that adolescent intermittent ethanol vapor (AIE) produces sex-dependent changes in glutamatergic activity in the bed nucleus of the stria terminalis (BNST) and behavioral outcomes following acute restraint stress in adulthood. In females, AIE disrupts group 1 metabotropic glutamate (mGlu1/5) receptor activity and enhances anhedonia-like behavior. The current study site-specifically knocked down mGlu5 receptors in the BNST of male and female Grm5loxp mice, exposed them to AIE, and observed the interaction of AIE and stress on negative affect-like behaviors in adulthood. These negative affect-like behaviors included the novelty-induced hypophagia task following acute restraint stress, open field activity, and contextual fear conditioning. Overall, we replicated our previous findings that AIE enhanced anhedonia-like activity in the novelty-induced hypophagia task in females and fear acquisition in males. The primary effect of BNST-mGlu5 receptor knockdown was that it independently enhanced anhedonia-like activity in females. Correlation analyses revealed that behavior in these paradigms showed poor interdependence. These results indicate that preclinical models of negative affective-like states encompass distinct features that may have independent, clinically relevant mechanisms. Further, modulating mGlu5 receptors is a prospective treatment target for females experiencing anhedonic-like states that make them susceptible to alcohol relapse.
Subject terms: Molecular neuroscience, Genetics
Introduction
Adolescent alcohol use is known as one of the strongest predictors for the development of an alcohol use disorder (AUD)1, due in part to persistent neuroadaptations that may follow repeated use2,3. Alcohol use during this critical time period might increase the risk of developing a stress or anxiety disorder, which are more prevalent in females4,5. These disorders fall under the umbrella of “negative affect”; the emotional states that underlie numerous psychiatric disorders and are known to drive excessive alcohol drinking, particularly in women6–8. Therefore, adolescent alcohol exposure may produce long-term sex-dependent expression of emotional dysregulation that influences problematic drinking in women.
Many facets of negative affect, such as anxiety, depression, and hypervigilance, can be assessed using preclinical models. A recent review from the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Consortium indicates that adolescent alcohol exposure generally produces long-lasting changes in anxiety-like activity in adulthood in rodents9. Adolescent alcohol exposure has also been linked to alterations in despair/depressive-like behavior in adulthood that may be sex-dependent, but these results are not consistent10–16. The NADIA Consortium notes that these inconsistencies may be due to the alcohol exposure paradigm and that potential differences between sexes have not been systematically addressed9. Further, many studies utilize a limited number of behavioral tasks to observe negative affect-like states, even though negative affect is a multi-dimensional concept17–19. Recent work from our lab has demonstrated that adolescent alcohol intermittent ethanol vapor (AIE) results in sex-dependent expression of stress-induced negative affect-like states in adulthood. AIE did not alter basal anxiety- or anhedonic-like activity in the absence of stress. However, AIE-exposed female mice showed enhanced anhedonia-like activity in the novelty-induced hypophagia (NIH) task following restraint stress, whereas AIE-exposed male mice showed increased low-intensity foot shock-induced freezing20.
One region known to regulate mood-related behaviors is the sexually dimorphic bed nucleus of the stria terminalis (BNST)21. The BNST is a site of convergence for stress- and alcohol-related information7, which specifically mediate glutamatergic transmission22–24. Notably, AIE produces sex-dependent changes in glutamatergic transmission in the BNST of C57Bl/6J mice during acute withdrawal and in adulthood following stress. In male mice, these signaling changes are mediated by the GluN2B-containing NMDA receptors25, whereas in female mice they are mediated by group 1 metabotropic glutamate (mGlu1/5) receptors20.
Recent work in our lab has demonstrated that this disrupted mGlu1/5-mediated signaling in the BNST is associated with stress-induced anhedonic states in adulthood following AIE that are present in female, but not male, mice20. Preclinical studies have consistently implicated mGlu5 receptors in reducing alcohol intake and regulating alcohol-induced negative affect-like behavior across a diverse array of behavioral paradigms, including despair- and anxiety-like behaviors26. Further, human postmortem studies show sexually dimorphic mGlu5 receptor expression in individuals with major depressive disorder (MDD) compared to control samples. In the dorsolateral prefrontal cortex, female MDD patient tissue had increased mGlu5 expression, whereas male MDD patient tissue had decreased mGlu5 expression27. However, increased mGlu5 expression was observed in locus coeruleus neurons of male subjects with MDD28.
mGlu5 receptors may also serve as a biomarker for AUDs and interventions. Genetic variants in the mGluR-eEf2-AMPAR pathway, including GRM5, predict alcohol intake in community-based samples29. In healthy, low-drinking participants, mGlu5 receptor availability is positively associated with “feeling high” in response to alcohol30. Alcohol-dependent individuals show reduced mGlu5 receptor availability that widely recovers over 6 months of abstinence31,32, although smoking status may be a contributing variable33. Notably, mGlu5 availability is positively correlated with craving alcohol as a negative reinforcer and relapse in alcohol-dependent individuals, but recovery of mGlu5 availability over time is associated with reduced alcohol craving31–33. Beyond serving as a biomarker, one enticing aspect of investigating mGlu5 receptors is that they represent a clinically viable target. Current potential therapies have shown minimal adverse outcomes over relatively short-term treatment periods34–36, acute alcohol does not affect compound metabolism37, and a number of clinical trials have recently wrapped up or are currently recruiting participants to observe alcohol-associated outcomes38–41.
The current study sought to identify the role of BNST-specific regulation of mGlu5 receptors in negative affective-like behaviors. Using a Cre-lox strategy for the mGlu5 receptor gene, mGlu5 receptors were site-specifically knocked down in the dorsolateral BNST (dlBNST) of male and female mice. The mice were then exposed to AIE and allowed to age into adulthood, at which time anhedonia-like activity in the NIH task following restraint stress, basal anxiety-like activity in the open field, and foot shock-induced freezing were observed. We hypothesized that the AIE GFP-control mice would show the previously observed sex-dependent phenotypes20, and that mGlu5 receptor knockdown in the BNST would modulate this behavior in female mice. Elucidating the role of mGlu5 receptors in these behavioral phenotypes may lead to more effective approaches for treating AUDs and comorbid, sex-dependent negative affect-like symptomology.
Methods
Mice
Grm5loxp breeder pairs were generously provided by Dr. Danny Winder (Vanderbilt University, Nashville, TN; Jackson Laboratories, Bar Harbor, ME: B6.129-Grm5tm1.1Jixu/J) and bred in-house. Mice were weaned at PND21 and housed separately with littermates (2–5 per cage). Food and water were provided ad libitum. All procedures were approved by the Animal Care and Use Committee at Louisiana State University Health Sciences Center and followed the guidelines set forth by the National Institutes of Health42.
Stereotaxic surgery
A total of 95 mice (51 females, 44 males) received intracranial surgery targeting the dlBNST (AP: +0.14, L: ±0.8, D: −4.14) between PND22-29. The surgery protocol was modified from Moore and Boehm43. Briefly, mice were anesthetized using a ketamine/xylazine cocktail (1 ml of 100 mg/ml ketamine, 0.1 ml of 100 mg/ml xylazine, and 8.9 ml sterile saline) at a volume of 0.1 ml/10 g of weight. Mice were then placed on an Angle Two Small Animal Stereotaxic Instrument (Leica Microsystems, Wetzlar, Germany). rAAV5/CamkII-GFP-Cre (cre) or rAAV5-CamKIIa-eGFP (GFP; control) were obtained from the Gene Therapy Center Virus Vector Core Facility (The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina). The virus was infused at a rate of 100 nl/min for a total volume of 200 nl/side. Injectors were left in place for 5 min to allow time for the virus to diffuse from the tips. At least one mouse/cage received cre or control virus to reduce potential littermate confounds. Mice received 5 g/kg ketoprofen immediately, 24 h, and 48 h post-surgery and recovered for at least 4 d prior to vapor exposure. Surgeries for each cohort were completed within a 36-h window.
Western blot
Viral knockdown was confirmed using western blot for mGlu5 receptors (1:3000; AB5675; Millipore Sigma), normalized to GAPDH signal (1:10,000; AB8245; Abcam, Cambridge, MA), in 500-µm thick dlBNST-containing punches from AIE-naïve adult male and female mice as previously described20. Mice were infused with virus during adolescence.
Ethanol vapor exposure
Six mice died following surgery, leaving 48 females and 41 males to be run through vapor exposure and subsequent behavioral testing. Cages were randomized and assigned to air or ethanol exposure based on sex, vapor cohort, and parents. When possible, at least one cage/sex was run through air and ethanol in each cohort. Male and female mice were exposed in separate chambers that can be independently controlled to produce the same BAC in each sex. The ethanol vapor chambers were maintained to achieve BACs of ~200 mg/dL, which were monitored using non-experimental mice. Vapor exposure began between PND27-35 following previously published protocols25. Briefly, mice were placed into the chamber in their home cages overnight for two, 4-d cycles of 16 h vapor exposure. Mice were placed back in the vivarium for the 8 h out-of-chamber. The 4-d cycles were separated by 3 d.
Behavioral tasks
Mice were aged undisturbed until adulthood (PND70 + ). Most mice were run through all behavioral tasks (see Supplemental Table 1 for details).
NIH and acute restraint stress
Procedures were modified from previously published protocols44,45. Mice were given 2 h access to Ensure vanilla-flavored nutritional shake in their home cage in a dimly lit room (~70 lux) under a hood. Latency to consume Ensure was recorded on the second day of training; mice that failed to consume were run through the test portion but excluded from further NIH analyses. On the test day, mice were restrained in well-ventilated 50-mL conical tubes and left undisturbed for 1 h46 before being returned to their home cage for 1 h. Mice were then individually placed into empty standardized mouse cages under the hood with lights on (~300 lux) and given 45 min to consume Ensure. The testing sessions were video recorded and two individuals blind to treatment condition scored the latency to initiate consumption on the test day.
Open field activity
Three to four weeks later, mice (PND91+) were exposed to the open field arena (TruScan mouse arena, Coulbourn Instruments, 25 × 25 cm) of the contextual fear apparatus located in a sound-attenuated chamber for 3 min prior to shock administration. This 3 min period was used to assess basal anxiety-like activity, quantified as the % of total distance traveled in the center of the chamber.
Contextual fear conditioning
Procedures were modified from a previously published protocol46. Following the 3 min habituation period, mice were exposed to six shocks delivered on a 30-s variable inter-stimulus interval through the rod shock floor connected to the TruScan Photobeam LINC system. Shocks were 0.4 mA, 1 s duration for male mice and 0.3 mA, 500 ms for female mice. Our lab has previously validated these intensities as producing similar, low levels of freezing in C57Bl6/J mice that allow for the detection of heightened fear responses in AIE-exposed animals20. Approximately 24 h post-training, mice were re-exposed to the chamber for a 15 min extinction session during which no shocks were administered. Data measurements were collected using Tru Scan software on a Windows computer.
Histological confirmation
Following behavior, mice were initially perfused using 4% PFA under ketamine/xylazine and targets were checked in 100 µm slices. To achieve the best visualization, we switched to sacrificing the mice and using live slices (200–300 µm) for ex vivo imaging25. The infusion region was visualized by exciting GFP at 488 nm using a BXWI51 microscope (Olympus). Animals were considered hits when a majority of the fluorescence was located within the dlBNST. Three mice (1 male air-cre, 1 female air-cre, 1 female air-GFP) were removed due to off-target surgeries.
Statistical analysis
Only mice with injections determined to target the dlBNST were included in statistical analyses. (Total female mice analyzed: 11 air-GFP, 12 air-cre, 12 AIE-GFP, 11 AIE-cre. Total male mice analyzed: 11 air-GFP, 9 air-cre, 11 AIE-GFP, 9 air-cre. Target group sizes were determined by previous findings20). Male and female mice were analyzed separately due to sex-dependent AIE-induced changes in these behavioral tasks20. All data were checked for normality and GraphPad Prism software (ver. 8.3) was used for analyses. Two-way ANOVAs assessing vapor history*viral status were run for the NIH and open field tasks. A three-way ANOVA assessing time point*vapor history*viral status was run for the contextual fear paradigm, as well as two-way ANOVAs within each time point. All values are presented as means ± SEM with p ≤ 0.05 considered significant (two-tailed), adjusted for post-hoc analyses. The overall analyses were run once, combining data from 16 litters of mice run in seven distinct cohorts. Sidak’s post-hoc tests comparing air- vs. AIE-history within viral group were run to confirm replication of the baseline phenotypes previously observed in our lab20.
Results
Cre infusion significantly knocks down mGlu5 receptors in the dlBNST
The study timeline is shown in Fig. 1A. To validate the flox/cre strategy, mice were infused with cre or control virus at the adolescent timepoint and allowed to age into adulthood without vapor exposure. A t-test indicated that cre infusion targeting the dlBNST significantly reduced mGlu5 receptor expression normalized to GAPDH (p < 0.05, Fig. 1B, C), which could be visualized by optical excitation of the GFP tag (Fig. 1D).
Fig. 1. Cre infusion knocks down mGlu5 receptors in the dlBNST.
Experimental timeline (A). Cre virus infusion induced significant mGlu5 receptor knockdown in the dlBNST using western blot analysis of BNST tissue punches (B). Representative image of punch location indicated by arrow (Ci), representative western blots (Cii), and viral expression in the dlBNST (D). Female and male samples were run on separate blots. Cropping is indicated by surrounding white space (Cii). Panel (Di) was modified from Paxinos & Franklin79 coronal diagram Bregma 0.26 and highlighted region corresponding to the image in Dii. Dii was created by merging a bright-field image (color, merge channel: gray) and GFP image (color, merge channel: green) of the same image field using ImageJ. Scale bar = 100 μm. Data shown as mean ± SEM, ns = 5–6. *p < 0.05.
dlBNST mGlu5 receptor knockdown increases anhedonic-like behavior in female mice
The NIH task is a preclinical analogue of negative affect-associated despair and anhedonia. Restraint stress uncovers enhanced anhedonic-like behavior in AIE-exposed female, but not male, mice20. Further, these stress- and AIE-induced changes in NIH behavior can be modulated by systemic treatment with the mGlu5 receptor antagonist MTEP20. To test the role of BNST-specific mGlu5 receptors on this behavior, we site-specifically knocked down these receptors in the BNST. Mice were exposed to AIE, then restraint stress-induced changes in the NIH task were observed in adulthood (Fig. 2A, B).
Fig. 2. Anhedonic-like behavior in dlBNST mGlu5 receptor knockdown mice.
NIH timeline (A). Latency to consume an appetitive reinforcer in the home cage on the second day of training in female (i) and male (ii) mice. Data shown as mean ± SEM, ns = 11–12 for female mice and 8–11 for male mice. The proportion of female (iii) and male (iv) mice that consumed on the second day of training. Data shown as absolute numbers. NIH test day timeline (B). Change in latency to consume an appetitive reinforcer in an aversive environment following restraint stress in female (i) and male (ii) mice. Data shown as mean ± SEM, ns = 6–9 for female mice and 6–10 for male mice. Main effect at *p < 0.05.
On the second training day, prior to restraint stress, the latency to consume was measured in the home cage. A vapor history*viral status ANOVA revealed no significant interaction or main effects on latency to consume in female mice (p’s > 0.05; Fig. 2Ai). In male mice, a vapor history*viral status ANOVA revealed no significant interaction or main effects on latency to consume (p’s > 0.05; Fig. 2Aii), although there was a notable amount of variance in the GFP-infused group. Further, a chi-square test revealed that a significantly higher proportion of female mice failed to consume on the training day (13/46, 28.3%) compared to male mice (3/35, 8.6%) [χ2(1, N = 81) = 4.861, p < 0.05; Fig. 2Aiii, iv). These mice were run through the test day but were not included in the test day analyses.
To account for individual and intra-sex variability in consummatory latencies5,47, latencies on the test day were quantified as the change in consummatory latency from the training day20. In female mice, there was a significant main effect of vapor history [F(1,29) = 4.97, p < 0.05] and virus [F(1,29) = 7.27, p < 0.05] (Fig. 3Bi) but no interaction of vapor history*viral status on change in latency to consume on the test day following restraint stress (p > 0.05). AIE history and BNST mGlu5 receptor knockdown independently increased latency to consume under aversive conditions. Post-hoc tests revealed no significant effect of AIE-history within virus groups (Sidak p’s > 0.05). In male mice, we observed no significant interaction or main effects of vapor history and virus following restraint stress in the NIH task (p’s > 0.05, Fig. 3Bii). Overall, these results replicate our previous finding that restraint stress induces an anhedonic-like phenotype in adulthood in female mice with an AIE history20. Further, mGlu5 knockdown in the BNST enhances this anhedonic-like state in female, but not male mice.
Fig. 3. Basal anxiety-like activity in dlBNST mGlu5 receptor knockdown mice.
Open field timeline (A). Percent of total distance traveled in the center of the open field in female (B) and male (C) mice. Data shown as mean ± SEM, ns = 8–10 for female mice and 8–11 for male mice. **p < 0.05, ^p < 0.052.
dlBNST mGlu5 receptor knockdown enhances basal anxiety-like activity in males
Distance traveled in the center of the open field is a well-established model of anxiety-like activity48. In female mice, a vapor history*viral status ANOVA revealed no significant interaction or main effects (p’s > 0.05) on % of distance traveled in the center of the open field of the fear chamber in the 3 min prior to shock (Fig. 3A, B).
In male mice, a vapor history*viral status ANOVA revealed no significant effect of vapor history (p > 0.05), but a main effect of the virus [F(1,35) = 4.12, p = 0.05] and a significant interaction [F(1,31) = 5.47, p < 0.05] (Fig. 3C). Post-hoc analysis indicated that the effect of the virus was driven by the air-history group with mGlu5 receptor knockdown, with a strong trend towards a significant difference between air-cre and AIE-cre mice (Sidak’s; GFP: p > 0.05, cre: p = 0.052). Regardless of this, air-cre mice showed significantly greater anxiety-like activity than their air-GFP counterparts (p < 0.01).
dlBNST mGlu5 receptor knockdown does not alter contextual fear acquisition in either sex but disrupts extinction in female mice
Freezing behavior in the contextual fear task is considered to be a measurement of hypervigilant states49. Further, it is regulated by BNST activity50,51 and AIE exposure20 in male rodents. We induced freezing activity using low-intensity, unpredictable foot shocks20 (Fig. 4A). Although a vapor history*viral status ANOVA revealed no significant interaction or main effects (p’s > 0.05) on pre-shock freezing levels in female mice (Fig. 4B), there was a significant interaction effect in male mice [F(1,35) = 4.62, p < 0.05] without any significant main effects or differences between the groups (Fig. 4D). Change scores were used to account for these individual differences in basal freezing levels and intra-sex variability in behavior5,47. Freezing at all timepoints was adjusted for each individual mouse’s basal pre-shock freezing level (average freezing during the 30 s immediately preceding the shock). The fear acquisition was quantified as the change in freezing immediately post-shock (30 s), retention of contextual fear memory was quantified as the change in freezing during the initial 1 min re-exposure to the chamber 24 h following training, and extinction was quantified as the change in freezing after 8 min of re-exposure to the chamber with no shock presentation (Fig. 4A). Minute 8 was chosen because freezing levels begin to increase by minute 15 in this low-intensity foot shock task, possibly reflecting habituation to the chamber20.
Fig. 4. Contextual fear acquisition, retention, and extinction in dlBNST mGlu5 receptor knockdown mice.
Contextual fear timeline (A). Pre-shock freezing levels in female (B) and male (D) mice. Freezing levels across the task adjusted for pre-shock freezing levels in female (C) and male (E) mice, where 0 indicates no change from pre-shock freezing. Data shown as mean ± SEM, ns = 8–10 for female mice and 8–11 for male mice. Omnibus main effect at *p < 0.05 and ***p < 0.001. Within time point main effect of virus at #p < 0.05 or main effect of vapor at &p < 0.05.
In female mice, a vapor history*viral status*time point ANOVA revealed a main effect of time point [F(1.92,65.14) = 8.81, p < 0.001]. Given our previous findings of time point-specific effects20, we also completed vapor history*viral status ANOVAs for each individual time point. We observed no significant interaction or main effects on fear acquisition within the training session or freezing during initial contextual re-exposure (p’s > 0.05; Fig. 4C). However, there was a significant main effect of the virus on freezing at extinction minute 8 [F(1,37) = 5.31, p < 0.05], where GFP mice showed less freezing (Fig. 4C).
In male mice, a vapor history*viral status*time point ANOVA only revealed a main effect of time [F(2.00,69.89) = 3.15, p < 0.05]. At the post-shock point, a vapor history*viral status ANOVA revealed no significant interaction or main effect of virus (p’s > 0.05), but a significant effect of vapor history on fear acquisition within the training session [F(1,35) = 4.98, p < 0.05] (Fig. 4E). However, Sidak’s post-hoc analyses revealed that there was no significant effect of AIE-history within either viral status group (p’s > 0.05). No significant interaction or main effects were observed at the re-exposure or extinction minute 8 timepoints. These results support our previous finding that AIE-history enhances contextual fear acquisition within the training session in male mice20. Notably, this behavior was not affected by mGlu5 receptor knockdown in the BNST.
Negative affect-like facets have minimal interdependency
Negative affective states represent a cluster of symptoms6, yet many preclinical studies are unable to investigate the relationship between these symptoms. Because most mice in the current study were run through all behavioral tasks, we were able to assess the individual relationships between basal anxiety (% center distance, NIH train latency), anhedonia (NIH test day latency), and hypervigilance (fear acquisition, re-exposure freezing, and extinction freezing). Detailed analyses revealed that vapor history and viral status had minimal influence on the relationships between these behavioral factors of negative affect, suggesting poor interdependence between components of negative affective-like states (see the Supplementary material and Supplemental Table 2 for more comprehensive analyses).
Discussion
The current study replicates our previous findings that AIE history and stress in adulthood produce sex-specific behavioral outcomes in preclinical tasks that characterize negative affective-like states and are related to BNST dysregulation (summarized in Table 1). In female mice, AIE history and restraint stress increased latency to consume an appetitive reinforcer, indicating an enhanced anhedonic-like state that was independently increased by BNST-mGlu5 receptor knockdown. This notable finding points to specific effects of BNST mGlu5 signaling in regulating anhedonic behavior in female mice. Female mice with mGlu5 knockdown also displayed persistent freezing at the extinction time point compared to viral control mice in a manner that was not modulated by AIE. In males, AIE history enhanced fear acquisition within the training session but mGlu5 knockdown did not alter this response. However, mGlu5 knockdown did increase basal anxiety levels in male mice.
Table 1.
Summary of findings.
| NIH test latency | Open field test | Fear conditioning | ||||
|---|---|---|---|---|---|---|
| Air | AIE | Air | AIE | Air | AIE | |
| Female mice | ||||||
| GFP | Increased latency in AIE compared to air #, and increased latency in Cre compared to GFP | No change in % center distance for vapor history*viral status | (Control) | No change from control | ||
| Cre | mGlu5 knockdown enhanced freezing during extinction regardless of vapor treatment | |||||
| Male mice | ||||||
| GFP | No change in NIH latency for vapor history*viral status | (Control) | No change from control | (Control) | Enhanced fear acquisition # regardless of viral status | |
| cre | mGlu5 knockdown decreased % Center Distance (increased negative affective-like behavior) | No change from control | No change from control | |||
Summary of experimental findings. The pound sign (#) indicates replications of previous work.
AIE produces distinct behavioral profiles mediated by BNST-mGlu5 receptors
Previous work using the NIH task has indicated that AIE history enhances latency to consume an appetitive reinforcer in female mice, but only following restraint stress20. In the current work, BNST-mGlu5 receptor knockdown increased the latency to consume on the NIH test day independent of AIE history in female mice but did not affect this behavior in male mice. This finding suggests that mGlu5 receptor signaling is required for maintaining baseline behavior, specifically in female mice, and that mGlu5 dysregulation increases anhedonic-like behavior regardless of prior insults. Interestingly, adult female mice with an AIE history show enhanced group 1 mGlu-mediated long-term depression (LTD) in the BNST following restraint stress, while male mice do not. This enhanced LTD is partially mediated by mGlu5 receptors20. In this previous work, overall mGlu5 levels were not altered by AIE in male or female mice20. However, these measurements were not able to determine whether the levels of mGlu5 receptors expressed in the plasma membrane were reduced. Alternatively, BNST-mGlu5 receptor knockdown could upregulate compensatory signaling (e.g., mGlu1 receptors or endocannabinoid signaling). Although the current studies are unable to differentiate between these two possibilities, they highlight the important role that mGlu5 signaling plays in regulating negative affect-like states in female mice. Further, it is possible that the results of these studies may have been different if the mGlu5 receptor knockdown surgery occurred after AIE treatment during late adolescence/early adulthood instead of prior to AIE during early adolescence. Due to the emergence of negative affective-like behaviors during adolescence4, these studies focused on concurrent mGlu5 receptor knockdown and vapor exposure during adolescent development to better capture relevant changes in mGlu5 signaling that may occur through the entirety of adolescence and play a role in alcohol-induced negative affect26.
In adult male mice, restraint stress enhances GluN2B-mediated signaling in the BNST of mice with an AIE history25. BNST-GluN2B receptors have been directly implicated in increased consumption latencies in the NIH task in male mice45. These results suggest that sexually divergent mechanisms identified in the BNST are directly related to distinct behavioral outcomes. Group 1 mGlu receptor regional expression levels or intracellular signaling cascades have been historically studied in male rodents. Sex differences in these signaling cascades have not been evaluated in the BNST. One aspect where known sex differences do exist is in convergence of estrogen and mGlu5 receptor intracellular signaling, whereby mGlu5 signaling can mediate estradiol-driven potentiation of psychostimulant-induced behaviors in female rodents (reviewed in ref. 52).
These distinct mechanisms are further supported by the subthreshold contextual fear results in males. This paradigm was used as a model of hypervigilance48, a facet of emotional behavior that is regulated by the BNST in humans and animals21,50,51,53,54. Although we observed increased post-shock freezing in AIE-exposed male mice, there was no influence of mGlu5 receptor knockdown on this behavior. As observed previously20, AIE history did not significantly alter fear acquisition within the training session in female mice. However, BNST-mGlu5 receptor knockdown did increase freezing in female mice at the extinction timepoint. It is unclear whether this represents persistent fear or is indicative of acclimation to the chamber. The latter appears to be the case in AIE-cre female mice, which showed relatively low levels of freezing at the re-exposure timepoint. This male-specific enhanced fear acquisition within the training session may also be indicative of increased BNST-GluN2B-mediated signaling25. Fyn kinase, which regulates GluN2B phosphorylation, has been shown to mediate contextual fear conditioning55–57. Previous work has indicated that high alcohol-preferring mice exposed to cued fear conditioning and allowed free access to alcohol show enhanced hypervigilance in the fear-potentiated startle task, regardless of sex. However, fear conditioning only caused immediate increases in alcohol intake in male mice58. Another model using unpredictable chronic mild stress showed that an alcohol history plus stress increased binge drinking in male, but not female, mice59. Although these studies fundamentally differ from the current model, they may suggest that the hypervigilant state in males driven by adolescent alcohol exposure may fuel increased alcohol intake in adulthood.
Sex-dependent effects were also observed in the open field, where BNST-mGlu5 knockdown increased anxiety-like behavior in air-cre, but not AIE-cre, mice. Previous work observing the effects of adolescent alcohol exposure on anxiety indices in adulthood has shown contradictory effects10–12,20. Further, the handful of studies observing the role of mGlu5 receptors in adult anxiety-like activity following adolescent alcohol exposure have not demonstrated clear effects of intervention12,60. It could be speculated that BNST-mGlu5 knockdown reduced gating of a male-specific neurocircuit involved in the expression of anxiety-like activity. For example, the kappa opioid-mediated basolateral amygdala to BNST projection regulates the unconditioned anxiety-like activity and mediates excitatory activity in the BNST61. Whether such circuits are male-specific and mediated by alcohol exposure is unknown.
These sex-specific enhancements of negative affect-like behavior in mGlu5 knockdown mice are surprising given the role of mGlu5 antagonists and negative allosteric modulators in treating depression- and anxiety-like behavior in rodents, as well as the observed behavioral phenotypes of global mGlu5 knockout (KO) animal models. There are numerous possible explanations for the discrepancy between the current results and this literature. First, mGlu5 receptors in the current study are not abolished but are closer to a 60% reduction (see Fig. 1B). There is evidence in some studies that mGlu5 heterozygous (HET) and KO mice show divergent phenotypes from their wild-type counterparts. For example, HET mice show an enhancement of operant sensation seeking, whereas KO mice show a reduction in their behavioral response62. The mice in the current study may be more similar to the HET mice receptor levels versus complete KO. However, divergence in HET/KO phenotypes has not generally been seen in studies of generalized anxiety, although to our knowledge NIH has not been assessed. The second potential explanation could be due to the site- and circuit-level roles of the BNST in anxiety and anhedonic behaviors. Optogenetic studies have shown that the behavioral valence outcome of BNST modulation depends on the subnuclei activated63. While Cre expression in this study (and thus mGlu5 receptor knockdown) does not seem to be confined to a particular subnuclei, it is possible that mGlu5 receptor gating of excitatory transmission in this region may have divergent actions. Alternatively, mGlu5 knockdown throughout the BNST may change the activity of specific circuits involved in negative affect-like behaviors. The BNST is a highly interconnected brain region, with reciprocal connections to other regions known to be involved in negative affect, including the cortex, amygdala, and ventral tegmental area64–66. mGlu5 receptor knockdown may disrupt LTD in the BNST, particularly in female mice following stress20,67,68. Disrupted LTD in the BNST could disturb the balance of excitatory and inhibitory transmission throughout these circuits, resulting in disrupted behavioral outcomes.
Translational relevance
These findings have robust clinical relevance for investigating underlying mechanisms of the sexually dimorphic risks associated with problematic alcohol use. The NIH task is a model of anhedonia, a classic symptom of depression44. Notably, depressive symptoms are stronger drivers of initial and continued alcohol use in young girls and women compared to young boys and men8. A recent Phase II clinical trial reported that the mGlu5 negative allosteric modulator basimglurant did not significantly reduce clinician-rated symptoms of MDD in a large sample of individuals without recent alcohol abuse. However, the high dose group (69.4% female) showed significant improvements in self-reported symptoms of depression36. In addition, recent genome-wide association studies consistently identify GRM5 as a significantly changed gene in patients with MDD69–71. Paired with the current findings, these results suggest that mGluR5 receptors present an encouraging druggable target and that targeting mGlu5 receptors may alleviate depressive states in women that could proceed problematic alcohol use.
Freezing to low-intensity, unpredictable foot shocks is indicative of a hypervigilant state49. Hypervigilance is a distinct facet of the hyperarousal criteria in post-traumatic stress disorder (PTSD)72. Although hypervigilance is characteristic of many disorders, like PTSD and generalized anxiety, it is specifically enhanced by unpredictable aversive events in individuals with PTSD73. Within PTSD, hypervigilance is a strong predictor of experiencing other PTSD-related outcomes74, which may be associated with problematic alcohol use. Women are more likely to be diagnosed with PTSD than men, but men may be more likely to present with a comorbid AUD75. In predominantly male veteran populations with comorbid AUD, hyperarousal is associated with intrinsic drinking motives and poor adherence to an online PTSD treatment program76,77. Although comorbid PTSD and AUD are strongly associated with emotional regulation facets of PTSD in women, this does not include hyperarousal78, similar to the findings in our preclinical model. Our findings may also indicate that adolescent alcohol exposure heightens the risk of developing PTSD-related symptoms.
Conclusion
Preclinical models with high face validity are necessary to develop treatments for AUDs and comorbid disorders. Although many studies have found that reducing mGlu5 activity alleviates alcohol-induced negative affective states, these studies have focused on males and have not widely included models of dependence. The current findings indicate that AIE produces sexually divergent behavioral phenotypes in adulthood that are unmasked by stress and reflect the human condition. The underlying symptoms and mechanisms of these factors also appear to be sexually divergent, with mGlu5 receptors playing a large role in depression-related risks in female mice. Notably, these behavioral facets showed poor interdependency, which is further indicative of distinct mechanisms. Overall, these findings support the use of mGlu5 receptors as a treatment target to alleviate negative affective states that may precipitate problematic drinking behavior.
Supplementary information
Acknowledgements
We would like to thank Benjamin Litchfield and Logan Palliser for their assistance in scoring videos. We would also like to thank Dr. Anis Contractor for generating the B6.129-Grm5tm.1.1.Jixu/J mice. This work was supported by the National Institute on Alcohol Abuse and Alcoholism (K99/R00 AA022651 and T32 AA007577) and LSUHSC REP funding.
Author contributions
C.R.K.: conceptualization, methodology, data collection, data analysis, writing—original draft preparation, writing—review and editing, visualization, supervision, project administration; E.B.H.: writing—review and editing; M.R.L.: data collection, data analysis, validation, writing—review and editing; T.A.W.: conceptualization, writing—review and editing, supervision, funding acquisition.
Conflict of interest
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Chelsea R. Kasten, Eleanor B. Holmgren
Supplementary information
The online version contains supplementary material available at 10.1038/s41398-021-01285-y.
References
- 1.Nixon K, McClain JA. Adolescence as a critical window for developing an alcohol use disorder: current findings in neuroscience. Curr. Opin. Psychiatry. 2010;23:227–232. doi: 10.1097/YCO.0b013e32833864fe. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ehlers CL, Criado JR. Adolescent ethanol exposure: does it produce long-lasting electrophysiological effects? Alcohol. 2010;44:27–37. doi: 10.1016/j.alcohol.2009.09.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Becker HC. Alcohol dependence, withdrawal, and relapse. Alcohol Res. Health. 2008;31:348–361. [PMC free article] [PubMed] [Google Scholar]
- 4.Craske MG, et al. Anxiety disorders. Nat. Rev. Dis. Prim. 2017;3:17024. doi: 10.1038/nrdp.2017.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Rubinow DR, Schmidt PJ. Sex differences and the neurobiology of affective disorders. Neuropsychopharmacology. 2019;44:111–128. doi: 10.1038/s41386-018-0148-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Brown TA, Barlow DH. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment. Psychol. Assess. 2009;21:256–271. doi: 10.1037/a0016608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35:217–238. doi: 10.1038/npp.2009.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Peltier MR, et al. Sex differences in stress-related alcohol use. Neurobiol. Stress. 2019;10:100149. doi: 10.1016/j.ynstr.2019.100149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Crews FT, et al. Mechanisms of persistent neurobiological changes following adolescent alcohol exposure: NADIA Consortium Findings. Alcohol Clin. Exp. Res. 2019;43:1806–1822. doi: 10.1111/acer.14154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ehlers CL, Liu W, Wills DN, Crews FT. Periadolescent ethanol vapor exposure persistently reduces measures of hippocampal neurogenesis that are associated with behavioral outcomes in adulthood. Neuroscience. 2013;244:1–15. doi: 10.1016/j.neuroscience.2013.03.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ehlers CL, Criado JR, Wills DN, Liu W, Crews FT. Periadolescent ethanol exposure reduces adult forebrain ChAT+IR neurons: correlation with behavioral pathology. Neuroscience. 2011;199:333–345. doi: 10.1016/j.neuroscience.2011.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lee KM, et al. mGlu5 receptor blockade within the nucleus accumbens shell reduces behavioral indices of alcohol withdrawal-induced anxiety in mice. Front Pharmacol. 2018;9:1306. doi: 10.3389/fphar.2018.01306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lee KM, Coehlo MA, Solton NR, Szumlinski KK. Negative affect and excessive alcohol intake incubate during protracted withdrawal from binge-drinking in adolescent, but not adult, mice. Front Psychol. 2017;8:1128. doi: 10.3389/fpsyg.2017.01128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Rico-Barrio, I. et al. Cognitive and neurobehavioral benefits of an enriched environment on young adult mice after chronic ethanol consumption during adolescence. Addict Biol. 10.1111/adb.12667 (2018). [DOI] [PubMed]
- 15.Szumlinski KK, et al. DID it or DIDn’t it? Exploration of a failure to replicate binge-like alcohol-drinking in C57BL/6J mice. Pharm. Biochem. Behav. 2019;178:3–18. doi: 10.1016/j.pbb.2018.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Van Waes V, et al. Impact of early life stress on alcohol consumption and on the short- and long-term responses to alcohol in adolescent female rats. Behav. Brain Res. 2011;221:43–49. doi: 10.1016/j.bbr.2011.02.033. [DOI] [PubMed] [Google Scholar]
- 17.Wright JS, Panksepp J. Toward affective circuit-based preclinical models of depression: sensitizing dorsal PAG arousal leads to sustained suppression of positive affect in rats. Neurosci. Biobehav. Rev. 2011;35:1902–1915. doi: 10.1016/j.neubiorev.2011.08.004. [DOI] [PubMed] [Google Scholar]
- 18.Kirlic N, et al. Latent variable analysis of negative affect and its contributions to neural responses during shock anticipation. Neuropsychopharmacology. 2019;44:695–702. doi: 10.1038/s41386-018-0187-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Goodwill HL, et al. Early life stress leads to sex differences in development of depressive-like outcomes in a mouse model. Neuropsychopharmacology. 2019;44:711–720. doi: 10.1038/s41386-018-0195-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kasten CR, et al. Adolescent alcohol exposure produces sex differences in negative affect-like behavior and group I mGluR BNST plasticity. Neuropsychopharmacology. 2020;45:1306–1315. doi: 10.1038/s41386-020-0670-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol. Psychiatry. 2016;21:450–463. doi: 10.1038/mp.2016.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kash TL, Baucum AJ, 2nd, Conrad KL, Colbran RJ, Winder DG. Alcohol exposure alters NMDAR function in the bed nucleus of the stria terminalis. Neuropsychopharmacology. 2009;34:2420–2429. doi: 10.1038/npp.2009.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wills TA, et al. GluN2B subunit deletion reveals key role in acute and chronic ethanol sensitivity of glutamate synapses in bed nucleus of the stria terminalis. Proc. Natl Acad. Sci. USA. 2012;109:E278–E287. doi: 10.1073/pnas.1113820109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Conrad KL, Louderback KM, Gessner CP, Winder DG. Stress-induced alterations in anxiety-like behavior and adaptations in plasticity in the bed nucleus of the stria terminalis. Physiol. Behav. 2011;104:248–256. doi: 10.1016/j.physbeh.2011.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Carzoli KL, et al. Regulation of NMDA receptor plasticity in the BNST following adolescent alcohol exposure. Front. Cell Neurosci. 2019;13:224. doi: 10.3389/fncel.2019.00440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kasten CR, Holmgren EB, Wills TA. Metabotropic glutamate receptor subtype 5 in alcohol-induced negative affect. Brain Sci. 2019;9:183. doi: 10.3390/brainsci9080183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Gray AL, et al. Sex differences in glutamate receptor gene expression in major depression and suicide. Mol. Psychiatry. 2015;20:1057–1068. doi: 10.1038/mp.2015.91. [DOI] [PubMed] [Google Scholar]
- 28.Chandley MJ, et al. Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression. Int. J. Neuropsychopharmacol. 2014;17:1569–1578. doi: 10.1017/S1461145714000662. [DOI] [PubMed] [Google Scholar]
- 29.Meyers JL, et al. Frequency of alcohol consumption in humans; the role of metabotropic glutamate receptors and downstream signaling pathways. Transl. Psychiatry. 2015;5:e586–e586. doi: 10.1038/tp.2015.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Leurquin-Sterk G, et al. Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study. Addict. Biol. 2018;23:931–944. doi: 10.1111/adb.12542. [DOI] [PubMed] [Google Scholar]
- 31.Leurquin-Sterk G, et al. Lower limbic metabotropic glutamate receptor 5 availability in alcohol dependence. J. Nucl. Med. 2018;59:682–690. doi: 10.2967/jnumed.117.199422. [DOI] [PubMed] [Google Scholar]
- 32.Ceccarini J, et al. Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients. J. Nucl. Med. 2020;61:256–262. doi: 10.2967/jnumed.119.228825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Akkus F, et al. Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder. Transl. Psychiatry. 2018;8:17. doi: 10.1038/s41398-017-0066-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zerbib F, et al. Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharm. Ther. 2011;33:911–921. doi: 10.1111/j.1365-2036.2011.04596.x. [DOI] [PubMed] [Google Scholar]
- 35.AstraZeneca. 6-week study treatment to evaluate the safety and effectiveness of AZD2066 in patients with major depressive disorder. https://clinicaltrials.gov/ct2/show/NCT01145755 (2012).
- 36.Quiroz JA, et al. Efficacy and safety of basimglurant as adjunctive therapy for major depression. JAMA Psychiatry. 2016;73:675. doi: 10.1001/jamapsychiatry.2016.0838. [DOI] [PubMed] [Google Scholar]
- 37.Haass-Koffler CL, et al. Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: a translational study in rats and humans. J. Psychopharmacol. 2018;32:163–173. doi: 10.1177/0269881117746904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN - Full Text View - Clinical Trials. gov. https://clinicaltrials.gov/ct2/show/NCT03341715 (2019).
- 39.Mavoglurant in Alcohol Drinking - Full Text View - Clinical Trials. gov. https://clinicaltrials.gov/ct2/show/NCT03327792 (2020).
- 40.Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals with Alcohol Use Disorder - Full Text View - Clinical Trials. gov. https://clinicaltrials.gov/ct2/show/NCT03418623 (2020).
- 41.Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent - Full Text View - Clinical Trials. gov. https://clinicaltrials.gov/ct2/show/NCT01842503 (2019).
- 42.Guide for the Care and Use of Laboratory Animals. vol. 46. Eighth. (The National Academies Press, 2011). [PubMed]
- 43.Moore EM, Boehm II SL. Site-specific microinjection of baclofen into the anterior ventral tegmental area reduces binge-like ethanol intake in male C57BL/ 6J mice. Behav. Neurosci. 2009;123:555–563. doi: 10.1037/a0015345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Dulawa SC, Hen R. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci. Biobehav. Rev. 2005;29:771–783. doi: 10.1016/j.neubiorev.2005.03.017. [DOI] [PubMed] [Google Scholar]
- 45.Louderback KM, Wills TS, Muglia LJ, Winder DG. Knockdown of BNST GluN2B-containing NMDA receptors mimics the actions of ketamine on novelty-induced hypophagia. Transl. Psychiatry. 2013;3:e331. doi: 10.1038/tp.2013.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Heinrichs, S. C. & Koob, G. F. Application of experimental stressors in laboratory rodents. Curr Protoc. Neurosci. Chapter 8:Unit8.4 (2006). [DOI] [PubMed]
- 47.Shansky RM. Sex differences in PTSD resilience and susceptibility: challenges for animal models of fear learning. Neurobiol. Stress. 2015;1:60–65. doi: 10.1016/j.ynstr.2014.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Mohammad F, et al. Concordance and incongruence in preclinical anxiety models: systematic review and meta-analyses. Neurosci. Biobehav. Rev. 2016;68:504–529. doi: 10.1016/j.neubiorev.2016.04.011. [DOI] [PubMed] [Google Scholar]
- 49.Ganella DE, Kim JHYU. Developmental rodent models of fear and anxiety: from neurobiology to pharmacology. Br. J. Pharmacol. 2014;171:4556–4574. doi: 10.1111/bph.12643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Sullivan GM, et al. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience. 2004;128:7–14. doi: 10.1016/j.neuroscience.2004.06.015. [DOI] [PubMed] [Google Scholar]
- 51.Zimmerman JM, Maren S. The bed nucleus of the stria terminalis is required for the expression of contextual but not auditory freezing in rats with basolateral amygdala lesions. Neurobiol. Learn Mem. 2011;95:199–205. doi: 10.1016/j.nlm.2010.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Gross KS, Mermelstein PG. Estrogen receptor signaling through metabotropic glutamate receptors. Vitam. Horm. 2020;114:211–232. doi: 10.1016/bs.vh.2020.06.003. [DOI] [PubMed] [Google Scholar]
- 53.Knight LK, Depue BE. New frontiers in anxiety research: the translational potential of the bed nucleus of the stria terminalis. Front. Psychiatry. 2019;10:510. doi: 10.3389/fpsyt.2019.00510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Somerville LH, Whalen PJ, Kelley WM. Human bed nucleus of the stria terminalis indexes hypervigilant threat monitoring. Biol. Psychiatry. 2010;68:416–424. doi: 10.1016/j.biopsych.2010.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Isosaka T, Kida S, Kohno T, Hattori K, Yuasa S. Hippocampal Fyn activity regulates extinction of contextual fear. Neuroreport. 2009;20:1461–1465. doi: 10.1097/WNR.0b013e32833203a8. [DOI] [PubMed] [Google Scholar]
- 56.Isosaka T, et al. Activation of Fyn tyrosine kinase in the mouse dorsal hippocampus is essential for contextual fear conditioning. Eur. J. Neurosci. 2008;28:973–981. doi: 10.1111/j.1460-9568.2008.06405.x. [DOI] [PubMed] [Google Scholar]
- 57.Kojima N, Sakamoto T, Endo S, Niki H. Impairment of conditioned freezing to tone, but not to context, in Fyn-transgenic mice: relationship to NMDA receptor subunit 2B function. Eur. J. Neurosci. 2005;21:1359–1369. doi: 10.1111/j.1460-9568.2005.03955.x. [DOI] [PubMed] [Google Scholar]
- 58.Chester JA, Weera MM. Genetic correlation between alcohol preference and conditioned fear: Exploring a functional relationship. Alcohol. 2017;58:127–137. doi: 10.1016/j.alcohol.2016.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Quadir SG, et al. Complex interactions between the subject factors of biological sex and prior histories of binge-drinking and unpredictable stress influence behavioral sensitivity to alcohol and alcohol intake. Physiol. Behav. 2019;203:100–112. doi: 10.1016/j.physbeh.2017.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Lee KM, Coelho MA, Class MA, Szumlinski KK. mGlu5-dependent modulation of anxiety during early withdrawal from binge-drinking in adult and adolescent male mice. Drug Alcohol Depend. 2018;184:1–11. doi: 10.1016/j.drugalcdep.2017.10.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Crowley NA, et al. Dynorphin controls the gain of an amygdalar anxiety circuit. Cell Rep. 2016;14:2774–2783. doi: 10.1016/j.celrep.2016.02.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Olsen CM, Childs DS, Stanwood GD, Winder DG. Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5) PLoS ONE. 2010;5:e15085. doi: 10.1371/journal.pone.0015085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Kim SY, et al. Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature. 2013;496:219–223. doi: 10.1038/nature12018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Vranjkovic O, Pina M, Kash TL, Winder DG. The bed nucleus of the stria terminalis in drug-associated behavior and affect: a circuit-based perspective. Neuropharmacology. 2017;122:100–106. doi: 10.1016/j.neuropharm.2017.03.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Gungor NZ, Paré D. Functional heterogeneity in the bed nucleus of the stria terminalis. J. Neurosci. 2016;36:8038–8049. doi: 10.1523/JNEUROSCI.0856-16.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Ch’ng S, Fu J, Brown RM, McDougall SJ, Lawrence AJ. The intersection of stress and reward: BNST modulation of aversive and appetitive states. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2018;87:108–125. doi: 10.1016/j.pnpbp.2018.01.005. [DOI] [PubMed] [Google Scholar]
- 67.Grueter BA, et al. Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. J. Neurosci. 2006;26:3210–9. doi: 10.1523/JNEUROSCI.0170-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Grueter BA, McElligott ZA, Robison AJ, Mathews GC, Winder DG. In vivo metabotropic glutamate receptor 5 (mGluR5) antagonism prevents cocaine-induced disruption of postsynaptically maintained mGluR5-dependent long-term depression. J. Neurosci. 2008;28:9261–70. doi: 10.1523/JNEUROSCI.2886-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Wray NR, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 2018;50:668–681. doi: 10.1038/s41588-018-0090-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Gaspar HA, et al. Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder. Transl. Psychiatry. 2019;9:117. doi: 10.1038/s41398-019-0451-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Howard DM, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 2019;22:343–352. doi: 10.1038/s41593-018-0326-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Association AP, editor. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th edn. (2013).
- 73.Hoffart A, Langkaas TF, Øktedalen T, Johnson SU. The temporal dynamics of symptoms during exposure therapies of PTSD: a network approach. Eur. J. Psychotraumatol. 2019;10:1618134. doi: 10.1080/20008198.2019.1618134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Grillon C, et al. Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biol. Psychiatry. 2009;66:47–53. doi: 10.1016/j.biopsych.2008.12.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Gilpin NW, Weiner JL. Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder. Genes, Brain Behav. 2017;16:15–43. doi: 10.1111/gbb.12349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Livingston NA, et al. Changes in alcohol use, PTSD hyperarousal symptoms, and intervention dropout following veterans’ use of VetChange. Addict. Behav. 2020;107:106401. doi: 10.1016/j.addbeh.2020.106401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.McDevitt-Murphy ME, Luciano MT, Tripp JC, Eddinger JE. Drinking motives and PTSD-related alcohol expectancies among combat veterans. Addict. Behav. 2017;64:217–222. doi: 10.1016/j.addbeh.2016.08.029. [DOI] [PubMed] [Google Scholar]
- 78.Goldstein B, Bradley B, Ressler KJ, Powers A. Associations between posttraumatic stress disorder, emotion dysregulation, and alcohol dependence symptoms among inner city females. J. Clin. Psychol. 2017;73:319–330. doi: 10.1002/jclp.22332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Paxinos, G. & Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates. 2nd edn. (Academic Press, 2001).
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




